SARS-CoV Nucleocapsid A2 219-227 (HLA-A*02:01)

SARS-CoV Nucleocapsid A2 219-227 (HLA-A*02:01)
€80.00 *

Prices plus VAT plus shipping costs

Delivery time 2-3 days
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt

Amount in mg:

5 mg

  • EP14600_1
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute... more
Product information "SARS-CoV Nucleocapsid A2 219-227 (HLA-A*02:01)"
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike protein (S) and others. The nucleocapsid protein has different functions in the coronavirus replication cycle. SARS-CoV Nucleocapsid A2 219-227 (HLA-A*02:01) is a linear peptidic epitope studied as part of nucleoprotein from severe acute respiratory syndrome-related coronavirus. This peptide has been tested for immune reactivity in T cell assays and MHC ligand assays.

 
Sequence:LQLPQGTTL
Gene:N
Delivery: 2-3 days
C-Terminus:OH
N-Terminus:H
Purity:95%
Amount:1 mg
Counter Ion:TFA
Protein:Nucleoprotein
Species:SARS-CoV-2
Allele:HLA-A*02:01
Application :Flow Cytometry
Indication :Coronavirus(COVID-19)
Viewed